Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Neuro-Oncology | April 4, 2018 | Volume: 20 | Issue: 9 | Pages: 1240-1250
10.1093/neuonc/noy053
| PMID 29660006